pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,499
stories
Jul 29, 26
STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drug
stat
Jul 29, 26
Opinion: The VA could help America win the biotechnology race with China
stat
Jul 29, 26
STAT+: In the biotech industry, a most-wanted fugitive was long hiding in plain sight
stat
Jul 29, 26
Vertex’s latest autoimmune TCE play involves $28M upfront to AbCellera
fiercebiotech
Jul 28, 26
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
stat
Jul 28, 26
GSK prepares for patent cliff with $2.5B cost-cutting plan
biopharma dive
Jul 28, 26
GSK shares rise as $2.5B cost-cutting plan unveiled
biospace
Jul 28, 26
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
stat
Jul 28, 26
STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment
stat
Jul 28, 26
FDA says Replimune’s melanoma data package is ‘not interpretable,’ setting up tough adcomm
biospace
Jul 28, 26
Eli Lilly tops new biopharma ranking on launch success, development speed
fiercebiotech
Jul 28, 26
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
biospace
Jul 28, 26
Oak Hill takes SPAC track to Nasdaq with Roche asset in tow
biospace
Jul 28, 26
Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options
fiercebiotech
Jul 28, 26
GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard
fiercebiotech
Jul 28, 26
Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
fiercebiotech
Jul 28, 26
GSK partner Hansoh reports another phase 3 win for priority ADC
fiercebiotech
Jul 27, 26
FDA scientists question Capricor data; Legend CEO steps down
biopharma dive
Jul 27, 26
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
biospace
Jul 27, 26
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
biopharma dive
Jul 27, 26
Legend CEO Ying Huang resigns; Carvykti chief named interim leader
endpoints
Jul 27, 26
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
biospace
Jul 27, 26
Updated: AstraZeneca foresees blockbuster sales for Claudin 18.2 ADC, but Ultomiris flops in rare disease
endpoints
Jul 27, 26
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
Jul 27, 26
Legend Biotech CEO abruptly steps down without permanent replacement
fiercebiotech
Jul 27, 26
From confidence to capital: Positioning biotech for the next growth cycle
biopharma dive
Jul 27, 26
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
biospace
Jul 27, 26
AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates
fiercebiotech
Jul 27, 26
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
biospace
Jul 27, 26
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
biospace
← prev
page 28 of 50
next →
